MKMartin Kjellberg

Martin Kjellberg

*This is an algorithmically generated author record based on publicly available information.

Martin Kjellberg has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population

    by Hirotaka Ieki, Sai Zhang, Satoshi Koyama, Martin Kjellberg, Hiroki Yoshida, Ryo Kurosawa, Hiroshi Matsunaga, Kazuo Miyazawa, Nobuyuki Enzan, Changhoon Kim, et al.

    BACKGROUND: GWASs (genome-wide association studies) have advanced our understanding of coronary artery disease (CAD) genetics and enabled the development of polygenic risk scores (PRSs) for estimating genetic risk based on common variant burden. However, GWASs have limitations in analyzing rare variants due to insufficient statistical power, thereby constraining PRS performance. METHODS: We conducted whole-genome sequencing of 1752 Japanese patients with CAD and 3019 controls. A machine learning-based analytical framework was applied to identify and interpret rare genetic variants associated with CAD pathogenesis. RESULTS: This approach identified 59 CAD-related genes, including known causal genes such as LDLR and those not previously captured by GWASs. A rare variant-based risk score derived from the framework demonstrated distinct clinical characteristics compared with a conventional common variant-based PRS. The rare variant-based risk score significantly discriminated CAD cases and predicted cardiovascular mortality in an independent cohort. Furthermore, combining the rare variant-based risk score with the traditional PRS improved CAD prediction compared with the PRS alone (area under the curve, 0.66 versus 0.61; P =0.007). CONCLUSIONS: These findings underscore the distinct and complementary value of the rare variant-based risk score compared with the conventional PRS, highlighting the enhanced predictive power achieved through their integration. This comprehensive approach proposes broader genetic profiling, offering substantial potential for improved clinical risk stratification and personalized prevention strategies.

  • Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon

    by Angelica Maria Delgado-Vega, Helene Cederroth, Fulya Taylan, Katja Ekholm, Marlene Ek, Håkan Thonberg, Anders Jemt, Daniel Nilsson, Jesper Eisfeldt, Kristine Bilgrav Saether, et al.

    In the first-ever Undiagnosed Hackathon, nearly 100 experts from 28 countries combined advanced phenotyping and genomic techniques for 48 hours, ultimately providing diagnoses to 40% of the previously undiagnosed families. This inspiring model demonstrates the power of multidisciplinary collaboration and patient partnership in precision diagnostics.